168 related articles for article (PubMed ID: 21461569)
1. Myeloperoxidase G-463A polymorphism and risk of lung and prostate cancer in a Turkish population.
Arslan S; Pinarbasi H; Silig Y
Mol Med Rep; 2011; 4(1):87-92. PubMed ID: 21461569
[TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase -463G>A polymorphism and risk of primary lung cancer in a Korean population.
Park JH; Park JM; Kim EJ; Cha SI; Lee EB; Kim CH; Kam S; Jung TH; Park JY
Cancer Detect Prev; 2006; 30(3):257-61. PubMed ID: 16844322
[TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case-control study.
Zhu H; Yang L; Zhou B; Yu R; Tang N; Wang B
Carcinogenesis; 2006 Dec; 27(12):2491-6. PubMed ID: 16829688
[TBL] [Abstract][Full Text] [Related]
4. Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant--463A of the myeloperoxidase gene.
Cascorbi I; Henning S; Brockmöller J; Gephart J; Meisel C; Müller JM; Loddenkemper R; Roots I
Cancer Res; 2000 Feb; 60(3):644-9. PubMed ID: 10676648
[TBL] [Abstract][Full Text] [Related]
5. Manganese superoxide dismutase Ile58Thr, catalase C-262T and myeloperoxidase G-463A gene polymorphisms in patients with prostate cancer: relation to advanced and metastatic disease.
Tefik T; Kucukgergin C; Sanli O; Oktar T; Seckin S; Ozsoy C
BJU Int; 2013 Aug; 112(4):E406-14. PubMed ID: 23773345
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation of myeloperoxidase gene contributes to atopic asthma susceptibility: a preliminary association study in Russian population.
Polonikov AV; Solodilova MA; Ivanov VP
J Asthma; 2009 Jun; 46(5):523-8. PubMed ID: 19544176
[TBL] [Abstract][Full Text] [Related]
7. Point: myeloperoxidase -463G --> a polymorphism and lung cancer risk.
Feyler A; Voho A; Bouchardy C; Kuokkanen K; Dayer P; Hirvonen A; Benhamou S
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1550-4. PubMed ID: 12496042
[TBL] [Abstract][Full Text] [Related]
8. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.
Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
Carcinogenesis; 2006 Mar; 27(3):525-32. PubMed ID: 16195240
[TBL] [Abstract][Full Text] [Related]
9. [Gene polymorphism of myeloperoxidase and genetic susceptibility to lung cancer].
Wu XM; Zhou YK; Ren S; Hao QL
Ai Zheng; 2003 Sep; 22(9):912-5. PubMed ID: 12969520
[TBL] [Abstract][Full Text] [Related]
10. Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk.
Schabath MB; Spitz MR; Delclos GL; Gunn GB; Whitehead LW; Wu X
Am J Ind Med; 2002 Jul; 42(1):29-37. PubMed ID: 12111688
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphism in myeloperoxidase but not GSTM1 is associated with risk of lung squamous cell carcinoma in a Chinese population.
Lu W; Xing D; Qi J; Tan W; Miao X; Lin D
Int J Cancer; 2002 Nov; 102(3):275-9. PubMed ID: 12397651
[TBL] [Abstract][Full Text] [Related]
12. Myeloperoxidase: new polymorphisms and relation with lung cancer risk.
Chevrier I; Stücker I; Houllier AM; Cenée S; Beaune P; Laurent-Puig P; Loriot MA
Pharmacogenetics; 2003 Dec; 13(12):729-39. PubMed ID: 14646692
[TBL] [Abstract][Full Text] [Related]
13. Association of the 463G-A myeloperoxidase gene polymorphism with gastric cancer risk.
Jiang Z; Zhang Z; Wang Z; Zhang G; Hu K; He B; Wang S
Hepatogastroenterology; 2012 May; 59(115):757-61. PubMed ID: 22094928
[TBL] [Abstract][Full Text] [Related]
14. Analysis of multiple single nucleotide polymorphisms (SNPs) of myeloperoxidase (MPO) to screen for genetic markers associated with acute leukemia in Chinese Han population.
Zhang J; Zhu FY; Pu YP; Yin LH; Luo J; Wang WP; Zhou GH
J Toxicol Environ Health A; 2007 Jun; 70(11):901-7. PubMed ID: 17479404
[TBL] [Abstract][Full Text] [Related]
15. The MPO -463G>A polymorphism and cancer risk: a meta-analysis based on 43 case-control studies.
Chu H; Wang M; Wang M; Gu D; Wu D; Zhang Z; Tang J; Zhang Z
Mutagenesis; 2010 Jul; 25(4):389-95. PubMed ID: 20418356
[TBL] [Abstract][Full Text] [Related]
16. Gender and smoking-related risk reduction of periodontal disease with variant myeloperoxidase alleles.
Meisel P; Krause T; Cascorbi I; Schroeder W; Herrmann F; John U; Kocher T
Genes Immun; 2002 Apr; 3(2):102-6. PubMed ID: 11960308
[TBL] [Abstract][Full Text] [Related]
17. Myeloperoxidase (MPO) -463G->A reduces MPO activity and DNA adduct levels in bronchoalveolar lavages of smokers.
Van Schooten FJ; Boots AW; Knaapen AM; Godschalk RW; Maas LM; Borm PJ; Drent M; Jacobs JA
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):828-33. PubMed ID: 15159316
[TBL] [Abstract][Full Text] [Related]
18. Role of MMP-1 1G/2G promoter gene polymorphism on the development of prostate cancer in the Turkish population.
Albayrak S; Cangüven O; Göktaş C; Aydemir H; Köksal V
Urol Int; 2007; 79(4):312-5. PubMed ID: 18025848
[TBL] [Abstract][Full Text] [Related]
19. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
Zhu Y; Spitz MR; Lei L; Mills GB; Wu X
Cancer Res; 2001 Nov; 61(21):7825-9. PubMed ID: 11691799
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants of myeloperoxidase and lung cancer risk.
Schabath MB; Spitz MR; Zhang X; Delclos GL; Wu X
Carcinogenesis; 2000 Jun; 21(6):1163-6. PubMed ID: 10837005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
